IRS1/2 degradation as a co-drug to be combined with pan-tyr/ser/thr kinase inhibitors to delay drug resistance

Original language	American English
State	Published - 2015
Event	AACR annual - Pensylvania, United States Duration: 18 Apr 2015 → 22 Apr 2015

Conference

Conference	AACR annual
Country/Territory	United States
City	Pensylvania
Period	18/04/15 → 22/04/15

Activities

• 1 Organizing a conference, workshop, ...

• AACR annual

  Hviv, I. (Participation - Conference participant)

  18 Apr 2015 → 22 Apr 2015

  Activity: Participating in or organizing an event › Organizing a conference, workshop, ...

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Reuveni, H., Kuperschmidt, L., Carmi, S., Moskovitz, N., Stemmer, S., & Haviv, I. (2015). IRS1/2 degradation as a co-drug to be combined with pan-tyr/ser/thr kinase inhibitors to delay drug resistance. Paper presented at AACR annual, Pensylvania, United States.

Reuveni, Hadas ; Kuperschmidt, Lana ; Carmi, Shani et al. / IRS1/2 degradation as a co-drug to be combined with pan-tyr/ser/thr kinase inhibitors to delay drug resistance. Paper presented at AACR annual, Pensylvania, United States.

@conference{ed699f3e3899407086c2e3fd3de29ee5,

title = "IRS1/2 degradation as a co-drug to be combined with pan-tyr/ser/thr kinase inhibitors to delay drug resistance",

author = "Hadas Reuveni and Lana Kuperschmidt and Shani Carmi and Neta Moskovitz and Salomon Stemmer and I. Haviv",

year = "2015",

language = "American English",

note = "AACR annual ; Conference date: 18-04-2015 Through 22-04-2015",

}

Reuveni, H, Kuperschmidt, L, Carmi, S, Moskovitz, N, Stemmer, S & Haviv, I 2015, 'IRS1/2 degradation as a co-drug to be combined with pan-tyr/ser/thr kinase inhibitors to delay drug resistance', Paper presented at AACR annual, Pensylvania, United States, 18/04/15 - 22/04/15.

IRS1/2 degradation as a co-drug to be combined with pan-tyr/ser/thr kinase inhibitors to delay drug resistance. / Reuveni, Hadas; Kuperschmidt, Lana; Carmi, Shani et al.
2015. Paper presented at AACR annual, Pensylvania, United States.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - IRS1/2 degradation as a co-drug to be combined with pan-tyr/ser/thr kinase inhibitors to delay drug resistance

AU - Reuveni, Hadas

AU - Kuperschmidt, Lana

AU - Carmi, Shani

AU - Moskovitz, Neta

AU - Stemmer, Salomon

AU - Haviv, I.

PY - 2015

Y1 - 2015

M3 - Paper

T2 - AACR annual

Y2 - 18 April 2015 through 22 April 2015

ER -

Reuveni H, Kuperschmidt L, Carmi S, Moskovitz N, Stemmer S, Haviv I. IRS1/2 degradation as a co-drug to be combined with pan-tyr/ser/thr kinase inhibitors to delay drug resistance. 2015. Paper presented at AACR annual, Pensylvania, United States.